Literature DB >> 20487894

Neuron-specific enolase as a marker of neuronal lesions during various comas in man.

H Scarna1, B Delafosse, R Steinberg, G Debilly, B Mandrand, A Keller, J F Pujol.   

Abstract

The detection of neuron-specific enolase in biological fluids has been investigated as an indirect marker of neuronal damage in man. This protein was measured by a sandwich enzymoimmunoassay in serums and cerebrospinal fluids from patients with consciousness disorders of various aetiologies. Neuron-specific enolase level was significantly increased in sera from patients with comas resulting from anoxemia, head injury, septic state, cirrhosis and fulminant hepatitis. On the other hand, patients with meningitis (affection not normally accompanied with neuronal lesion) exhibited no change of this marker level. The statistical analysis of our results suggests that, in neurological disorders, the neuron-specific enolase levels in cerebrospinal fluid could have some prognostic value. The correlation between its level in cerebrospinal fluid and in serum was also demonstrated. Neuron-specific enolase increase in biological fluids thus represents a useful and promising marker to biochemically characterize various strokes possibly resulting in neuronal damage.

Entities:  

Year:  1982        PMID: 20487894     DOI: 10.1016/0197-0186(82)90083-3

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  8 in total

Review 1.  Cerebrospinal fluid markers in neurological disorders.

Authors:  A R Massaro; G Scivoletto; P Tonali
Journal:  Ital J Neurol Sci       Date:  1990-12

Review 2.  Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood.

Authors:  Henrik Zetterberg; Douglas H Smith; Kaj Blennow
Journal:  Nat Rev Neurol       Date:  2013-02-12       Impact factor: 42.937

3.  The significance of neuron specific enolase levels in cerebrospinal fluid and serum after experimental traumatic brain damage.

Authors:  M Uzan; M Hanci; O Güzel; A C Sarioğlu; C Kuday; F Ozlen; M Y Kaynar
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

4.  Concentration of neuron-specific enolase and S100 protein in the subretinal fluid of rhegmatogenous retinal detachment.

Authors:  J C Quintyn; F Pereira; M F Hellot; G Brasseur; A Coquerel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-05-20       Impact factor: 3.117

5.  Elevated levels of the alpha subunit of GTP-binding protein Go in cerebrospinal fluid of patients with neurological disorders.

Authors:  T Murayama; A Takahashi; T Asano; K Kato
Journal:  J Mol Neurosci       Date:  1989       Impact factor: 3.444

6.  Determination of the glial fibrillary acidic protein in human cerebrospinal fluid and in cyst fluid of brain tumors.

Authors:  J Szymaś; S Morkowski; F Tokarz
Journal:  Acta Neurochir (Wien)       Date:  1986       Impact factor: 2.216

Review 7.  Clinical Applications of Extracellular Vesicles in the Diagnosis and Treatment of Traumatic Brain Injury.

Authors:  Kryshawna Beard; David F Meaney; David Issadore
Journal:  J Neurotrauma       Date:  2020-06-02       Impact factor: 4.869

8.  Loss of Mitochondrial Ndufs4 in Striatal Medium Spiny Neurons Mediates Progressive Motor Impairment in a Mouse Model of Leigh Syndrome.

Authors:  Byron Chen; Jessica Hui; Kelsey S Montgomery; Alejandro Gella; Irene Bolea; Elisenda Sanz; Richard D Palmiter; Albert Quintana
Journal:  Front Mol Neurosci       Date:  2017-08-24       Impact factor: 5.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.